SCHEMBL11344010

SCHEMBL11344010

Cc1ccc(NC(=O)Nc2ccc(C)c(C(=O)Nc3c(O)ccc4cccc(S(=O)(=O)O)c34)c2)cc1C(=O)Nc1c(O)ccc2cccc(S(=O)(=O)O)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
CD40 P25942 1/20 0.41
CD40LG P29965 1/20 0.41
IDH1 O75874 4/20 0.41
KDR P35968 2/20 0.40
LCK P06239 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
TTR P02766 1/20 0.39
FABP4 P15090 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK14 Q16539 1/20 0.39
ENPP2 Q13822 2/20 0.39
BRAF P15056 1/20 0.39
PRMT1 Q99873 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10995545 0.94 CD40 (0.41) KMT2APOLBCD40CD40LGTTR
SCHEMBL11346155 0.88 KMT2A (0.40) KMT2APOLBIDH1KDRLCK
SCHEMBL11346735 0.87 CD40 (0.45) KMT2APOLBCD40CD40LGIDH1
SCHEMBL11340787 0.85 PRMT1 (0.41) KMT2APOLBIDH1KDRLCK
SCHEMBL10823411 0.85 IDH1 (0.55) IDH1IDH2
SCHEMBL11348122 0.84 KMT2A (0.51) KMT2APOLBCD40CD40LGKDR
SCHEMBL11341346 0.83 CD40 (0.52) KMT2ACD40CD40LGCA1CA2
SCHEMBL11341037 0.83 KMT2A (0.52) KMT2APOLBCD40CD40LGIDH1
SCHEMBL11344331 0.83 HPSE (0.47) KMT2APOLBCD40CD40LGIDH1
SCHEMBL10907561 0.82 MAOB (0.40) KMT2APOLBCD40CD40LGBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed